We have found a human serum, E27, obtained from a multiply transfused patient with systemic lupus erythematosus, which immunoprecipitates the lymphocyte function associated antigen-1 (LFA-1). The immunoprecipitated molecules were identified as the LFA-1 alpha and beta chains by their comigration on SDS-PAGE, two-dimensional SDS-PAGE, and by sequential clearance experiments. Serum E27 did not immunoprecipitate LFA-1 from autologous cells, though LFA-1 molecules were present. In contrast, serum E27 immunoprecipitated LFA-1 from most but not all normal donor lymphocytes. Thus, serum E27 defines two serological phenotypes of LFA-1. 95% of normal individuals tested exhibited the LFA-1 phenotype precipitated by serum E27. Serum E27 appears to be directed at determinants of the LFA-1 a-chain and not the E-chain since it immunoprecipitated LFA-1 molecules but not the Mac-i molecules. Additional evidence for the alpha chain specificity was provided by immunoprecipitation of mouse-human heterohybridoma cells. LFA-1 was immunoprecipitated by serum E27 from mouse-human heterohybridoma cells expressing the human a-chain, not from a hybrid cell line expressing the human f-chain. Together these findings demonstrate an antigenic polymorphism of the human LFA-1 a-chain molecule.
Introduction
The lymphocyte function associated antigen-i (LFA-1)' molecules are cell surface glycoproteins important in leukocyte adhesion processes. They are heterodimers comprised of an a-polypeptide chain of 177,000 mol wt and a fl-polypeptide chain of 95,000 mol wt, noncovalently linked together (1) . LFA-I is one of a family of structurally similar molecules that also includes p150,95, and Mac-I (the complement receptor CR3). Mac-I is recognized by monoclonal antibodies (MAbs) Mac-1, Mo 1, and OKM1, and is composed of a distinct a-chain of 165,000 mol wt associated with a 95,000-mol wt (3-subunit. The LFA-I and Mac-I ,-subunits are apparently identical as indicated by identical isoelectric focusing patterns (2) and identical peptide maps (3, 4) . The LFA-1, Mac-I family also contains a third heterodimer, p150,95 composed of a distinct 150,000 mol wt a-chain linked with the common 95,000-mol-wt (-chain. The members of this family are all heterodimers sharing a common (-chain complexed with a unique a-subunits distinguished by size, isoelectric focusing point, and peptide patterns (2) .
The LFA-1 molecules are expressed on the surface of lymphocytes, thymocytes, monocytes, granulocytes, and bone marrow cells (5) . The Mac-i molecules are present on human monocytes, granulocytes, and natural killer cells, but are absent (or minimally present) on lymphocytes. The p150,95 heterodimer has been less well characterized but it appears to be recognized by the MAb Leu M5 and is present upon monocytes and, in low density, on granulocytes and large granular lymphocytes.
Little structural variability of any of these molecules has been described in man. Recently, a polymorphism of the CR3 complement receptor that binds C3bi has been reported (6) . A murine MAb was found to immunoprecipitate CR3 from 14% of individuals. That MAb did not react with LFA-1 and was thought to react with an epitope on the Mac-I a-chain.
No structural variation of the human LFA-1 molecules has been previously reported. We have identified a human serum, obtained from a patient with systemic lupus erythematosus who had previously received multiple blood transfusions, that immunoprecipitates LFA-I from lymphocytes of most but not all individuals. This serum appears to identify a phenotypic variation of the human LFA-1 molecules.
Methods
Cells and lymphocyte preparations. Peripheral blood mononuclear cells (PBMs) were obtained by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) density gradient centrifugation (7), pelleted, and washed thrice with RPMI. These cells were either used directly or further processed by passage through a nylon wool (NW) column (8) to yield NW T-enriched cells (T cells) before iodination.
Mouse X human heterohybridoma cells expressing LFA-l hybrid molecules have been previously described (9) . Human PHA blasts, obtained from the parent ofa LFA-l Mac-l deficient patient and the murine cell line BW5 147 were fused and hybrids selected for the expression of human a-or human (3- O'Farrell two-dimensional gel electrophoresis (2D-PAGE). 2D-PAGE was carried out after the method ofO'Farrell (14) as previously described (11) . Samples were eluted from the SAC or Sepharose immunoadsorbents by incubation with 8 M urea, 5% 2-ME for 60 min at 220C and applied to prefocused 6% acrylamide tube gels with 10 mM phosphoric acid (pH 3.9) and 50 mM Tris base (pH 9.9) electrode solutions, and focused for 10 h at 1,000 V. The gels were then equilibrated with SDS-PAGE diluent buffer and run on 8% SDS-PAGE in the second dimension and fixed and processed as described above for one-dimensional SDS-PAGE.
Results
Serum E27 immunoprecipitates two polypeptides that co-electrophoresed with the LFA-1 a-and j#-chains. In order to detect lymphocyte surface molecules reactive with the lupus serum E27, immunoprecipitation experiments were performed. NW purified T cells were isolated, and their cell surface proteins were iodinated with lactoperoxidase and reacted with serum from lupus patient E27. After detergent-solubilization, the iodinated surface molecules bound to antibody were immunoprecipitated and analyzed by SDS-PAGE (Fig. 1) . Serum E27 immunoprecipitated two iodinated cell surface molecules whose molecular weights were estimated to be 175,000 and 95,000 (lane 5). In addition, nonspecific bands of 80,000 and 50,000 mol wt are seen in the serum E27 precipitate and also in negative control samples (lanes I and 2). In some experiments serum E27 also precipitated chains of43,000 and 12,000 mol wt which comigrated with HLA chains (data not shown). Because the two larger E27-immunoprecipitated molecules had similar molecular weights to the subunits of LFA-1, their electrophoretic migration was compared with that of immunoprecipitates produced by LFA-l specific monoclonal antibodies TS1/22 and TSI/18 ( Fig. 1, lanes 3 and 4) . The 175,000-mol-wt band immunoprecipitated with E27 coelectrophoresed with the LFA-l a-chain and the 95,000-mol-wt band coelectrophoresed with the LFA-I p-chain. This suggested that serum E27 contained antibody reactive with the LFA-l molecules.
To more critically compare LFA-1 and the molecules precipitated with E27, they were analyzed by O'Farrell 2D-PAGE. Surface iodinated cells were reacted with serum E27 or LFA-1-specific MAb and immunoprecipitates prepared. The samples were denatured with urea, reduced with 2-ME and subjected to isoelectric focusing for 10 h followed by SDS-PAGE in the second LFA RX:
_--++ ++ Preclearance ofLFA-J molecules removes E27 reactive molecules. The identity ofthe molecules precipitated by E27 as LFA-1 was confirmed by preclearance experiments. Aliquots of radioiodinated lymphocytes were first incubated with either MAb specific for the LFA-l a-chain, LFA-lI3-chain, or a control MAb, and then the Ab-complexed molecules were removed. Next, the precleared extracts were immunoprecipitated with serum E27 or LFA-1 specific MAb and analyzed by SDS-PAGE. Clearance with MAb to LFA-1 a-or 1-subunits resulted in the substantial removal of the LFA-1 molecules (Fig. 3, lanes 2, 3, 5, 6 ) and the nearly complete depletion of the 1 75,000-mol-wt molecule normally immunoprecipitated by serum E27 (Fig. 3, lanes 8 (Fig. 5,  lanes 6 and 14) . Since an immunodeficiency syndrome involving the absence ofthe three related molecules constituting the LFA-1 family has been described (15) (16) (17) (18) (19) (20) (21) (22) (23) , the cells from the two individuals who did not react with serum E27 were reexamined to determine if they expressed LFA-l molecules on their cell surfaces. Both LFA-l a-and LFA-1 (3-chains could be immunoprecipitated from cells of both individuals by specific MAb (Fig. 6, lanes 4, 5, 7, 8 ) but again, as in the previous experiment, their LFA-l molecules did not react with serum E27 (Fig. 6,  lanes 6, 9) . 5% of individuals from the normal population examined thus expressed a phenotypic variant of LFA-I that does not react with serum E27. Physicochemical properties ofallotypic LFA-I molecules. The size and charge characteristics of the LFA-1 molecules isolated from one of the nonreactive individuals were compared with those of the more common LFA-I phenotype by O'Farrell 2D-PAGE (Fig. 7) . By this analysis the ,3-chain prepared from the E27-nonreactive individuals appeared to be identical to the LFA-1 13-chain of the E27-reactive individuals. The positions of the a-chains were also identical and although the more basic spots are fainter in this figure, other gels showed identical intensities as well as positions for the a-chains. This result indicated 12 Chain specificity ofserum E27. It was ofinterest to determine the portion of the LFA-1 molecules recognized by serum E27 since those antibodies probably recognize the altered portion of the LFA-1 molecules. Various approaches have been used to determine this. First when LFA-1 molecules were precipitated by serum E27 and the intensity of the a-chain band compared with that of the f-chain, several experiments demonstrated that the a-chain band was more intense than the fl-chain band (e.g., Fig. 1 ). This pattern of intensities is very similar to that produced by the LFA-1 a-chain specific MAb TS 1/22 and contrasts to the nearly even intensity of the a-and f-chains usually observed in immunoprecipitates produced with the LFA-1 fl-chain specific MAb TSI/18.
A second approach to the identification of the chain recognized by serum E27 has been to prepare LFA-1 immunoprecipitates containing both the LFA-1 a-and f-chains and subjecting these immunoprecipitates to incubation conditions with various pHs to partially dissociate the LFA-I subunits. Similar treatments have been used to partially denature and dissociate the a-and f-chains of LFA-I to show the preferential retention ofone chain or the other depending upon the epitope specificity of the MAb (7). E27 and LFA-l immunoprecipitates prepared from iodinated lymphocytes were treated for 30 min at 40C with solutions composed of 0.5 M NaCl, 0.5% NP-40, 100 mM diethylamine adjusted to pH 7.2, 10.7, 11.2, or 11.5, and then centrifuged and Analysis ofthe LFA-i chain specificity ofserum E27 using heterohybridoma cells. Mouse X Human heterohybridoma cells have been developed that retain the human chromosomes coding for either the human a-or human 13-chain of LFA-1 (9). One of those lines (MBXBW5+) expresses hybrid LFA-l molecules composed of human a-subunit associated with murine 1-chain.
Another line (MB1l33) expresses human LFA-1 1-chain in association with murine a-chain, and does not express human achains. Sublines MBXBW5-and MB13-were derived from these two lines and have lost the previously retained human chromosomes and no longer express the human LFA-1 a-or 1-chains, respectively. These cell lines were surface radioiodinated and reacted with serum E27 or with MAbs TSI/18, or TS1/22, and immunoprecipitates prepared and run on SDS-PAGE. As expected, human LFA-I a-and 1-chains were immunoprecipitated from human phytohemagglutinin (PHA) blast cells (Fig. 10 To the best of our knowledge this is the first description of an antigenic variation of the human LFA-I molecules. However, an allotypic variation of murine LFA-l has been described (4). The E27-reactive epitope is distinct from the TS1/22-reactive epitope of LFA-I since 'the MAb recognized both forms of the LFA-1 molecules. No other anti-LFA-I MAb have been shown to react with only a subset of human LFA-1 molecules. If as suspected, the difference between the two phenotypes of LFA-1 molecules arises from alteration of the a-chain structure, this could be the result of amino acid substitutions, multiple amino acid changes or various postranslational modifications. As indicated by the identical two-dimensional O'Farrell gel electrophoresis patterns of the normal and variant LFA-l a-chains, the variations do not have a large effect upon the molecular weight or the pI of the a-chain. For the molecules to have such similar two-dimensional electrophoretic patterns, the changes between them are probably minor and most likely involve one or a few amino acid substitutions.
This LFA-l variation contrasts with the inherited immunodeficiency syndrome involving the partial or complete deficiency of the Mac-1, LFA-I family of molecules (15) (16) (17) (18) (19) (20) (21) (22) (23) . Those patients synthesize normal a-chain precursor molecules but apparently don't synthesize normal ,-chains and as a consequence few dimers are formed (24, 25) . In vitro tests show their granulocyte and monocytes have defects in motility, adherence, and phagocytosis. In addition, they have diminished antibody dependent cell-mediated cytotoxicity (ADCC), and natural killer (NK) cell activity, and have subtle T cell abnormalities (26) .
MAb that bind specifically to the LFA-I glycoproteins have established the involvement of these molecules in several immunological events. Monoclonal antibodies directed at LFA-1 block T cell-mediated killing (1, 3, 5, (27) (28) (29) (30) (31) (32) (33) (34) , NK cell lysis (5, (31) (32) (33) 35) , ADCC (36, 37) , mitogen and antigen-induced responses (5) and neutrophil adherence processes (38 
